Stocks:
5,782
ETFs:
2,400
Exchanges:
11
Market Cap:
$53.67T
24h Vol:
$12.01B
Dominance:
AAPL:5.50%
Stocklytics Platform
Instrument logo  JNJ

Johnson & Johnson

JNJ
67 / 100
$154.661.67%$2.55

Performance History

Placeholder
Key Stats
Open$152.25
Prev. Close$152.11
EPS5.32
Dividend$4.64
Next Earnings DateJul 20, 2023
Dividend Yield %
3.13%
Market Cap
$372.30B
PE Ratio
29.07
lowhigh
Day Range151.92
155.14
52 Week Range144.95
181.03
Ratios
P/B Ratio
5.14
Revenue
$95.33B
Operating M. %
30.07%
Earnings
$34.62B
Earnings Growth %
483.80%
EBITDA Margin %
36.73%
ROE %
19.19%
EPS5.32

Score Breakdown

67vs 52. Market Avg.

All Score (67 / 100) is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

JNJMarket
Value
34
42
Quality
74
46
Ownership
94
39
Growth
56
44
Dividends
43
32

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$591.03
24H (%)-0.13%
24H ($)-$0.82
MARKET CAP$561.07B
PRICE$552.96
24H (%)3.36%
24H ($)$17.98
MARKET CAP$511.45B
PRICE$102.48
24H (%)1.33%
24H ($)$1.35
MARKET CAP$259.68B
PRICE$142.39
24H (%)2.80%
24H ($)$3.89
MARKET CAP$251.39B

About Johnson & Johnson (JNJ)

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

ISN
-
Sector
Healthcare
Industry
Drug Manufacturers—General
CEO
Mr. Joaquin Duato
Headquarters
New Brunswick
Employees
152700
add Johnson & Johnson to watchlist

Keep an eye on Johnson & Johnson

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.